HRP20110551T1 - Antagonisti cikličkog peptida cxcr4 - Google Patents
Antagonisti cikličkog peptida cxcr4 Download PDFInfo
- Publication number
- HRP20110551T1 HRP20110551T1 HR20110551T HRP20110551T HRP20110551T1 HR P20110551 T1 HRP20110551 T1 HR P20110551T1 HR 20110551 T HR20110551 T HR 20110551T HR P20110551 T HRP20110551 T HR P20110551T HR P20110551 T1 HRP20110551 T1 HR P20110551T1
- Authority
- HR
- Croatia
- Prior art keywords
- group
- glu
- lys
- absent
- asp
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pulmonology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Pain & Pain Management (AREA)
- AIDS & HIV (AREA)
- Hematology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US94080207P | 2007-05-30 | 2007-05-30 | |
| US94099607P | 2007-05-31 | 2007-05-31 | |
| PCT/US2008/064177 WO2008150689A1 (en) | 2007-05-30 | 2008-05-20 | Cyclic peptide cxcr4 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HRP20110551T1 true HRP20110551T1 (hr) | 2011-09-30 |
Family
ID=39831600
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HR20110551T HRP20110551T1 (hr) | 2007-05-30 | 2008-05-20 | Antagonisti cikličkog peptida cxcr4 |
Country Status (32)
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2942798B1 (fr) * | 2009-03-05 | 2011-04-08 | Centre Nat Rech Scient | Peptides utilisables pour le traitement de la leucemie lymphoide chronique |
| IT1397901B1 (it) * | 2010-01-26 | 2013-02-04 | Consiglio Nazionale Ricerche | Peptidi ciclici che legano il recettore cxcr4 e relativi usi in campo medico e diagnostico. |
| JPWO2012118124A1 (ja) * | 2011-03-01 | 2014-07-07 | 国立大学法人京都大学 | 新規ケモカイン受容体拮抗剤 |
| KR102091456B1 (ko) * | 2011-06-07 | 2020-03-23 | 폴리포 리미티드 | CXC4 길항제로서의 β-헤어핀 펩타이드 모방체 |
| CN104780930A (zh) * | 2011-09-30 | 2015-07-15 | 程云 | 丙型肝炎病毒免疫原性肽或其衍生物在预防或治疗关节炎中的应用 |
| WO2013060865A1 (en) | 2011-10-28 | 2013-05-02 | Galderma Research & Development | New leukocyte infiltrate markers for rosacea and uses thereof |
| EP2979991A1 (en) | 2014-07-31 | 2016-02-03 | Greif International Holding BV. | Multilayer material, fire protection mat with said multilayer material and transport and storage container assembly comprising said fire protection mat. |
| EP3613435A1 (en) | 2015-01-28 | 2020-02-26 | Universite De Bordeaux | Chemokine receptor cxcr4 inhibitors for treating and/or preventing chronic obstructive pulmonary disease |
| WO2017176565A1 (en) | 2016-04-07 | 2017-10-12 | Eli Lilly And Company | Combinations of an anti-b7-h1 antibody and a cxcr4 peptide antagonist for treating a solid tumor |
| CA3032885C (en) * | 2016-09-06 | 2023-06-20 | Mainline Biosciences | Cxcr4 antagonists and methods of use |
| CN106841624B (zh) * | 2017-01-26 | 2019-02-22 | 庄磊靓 | 抗人cd4和抗人cd184单克隆抗体作为标志物的应用 |
| JP2020532496A (ja) * | 2017-09-05 | 2020-11-12 | メインライン バイオサイエンシズ | 高親和性ｃｘｃｒ４選択的結合抱合体およびその使用方法 |
| US11123437B2 (en) * | 2017-09-05 | 2021-09-21 | Mainline Biosciences, Inc. | Selective CXCR4 binding peptide conjugate and methods for making and using the same |
| WO2019126796A1 (en) * | 2017-12-21 | 2019-06-27 | Mainline Biosciences Llc | Composition comprising a therapeutic agent and a cxcr4 selective antagonist and methods for using the same |
| JP2021165234A (ja) * | 2018-07-03 | 2021-10-14 | 富士フイルム富山化学株式会社 | Ｃｘｃｒ４結合性化合物もしくはその塩またはそれらと金属との錯体 |
| AU2019338221B2 (en) | 2018-09-12 | 2024-04-04 | Technische Universität München | CXCR4-targeted diagnostic and therapeutic agents with reduced species selectivity |
| WO2020053255A1 (en) | 2018-09-12 | 2020-03-19 | Technische Universität München | Therapeutic and diagnostic agents for cancer |
| JP7541532B2 (ja) * | 2019-04-18 | 2024-08-28 | プロビンシャル・ヘルス・サービシーズ・オーソリティ | 診断及び治療のための新規な放射性標識されたｃｘｃｒ４を標的とする化合物 |
| JP2023516878A (ja) * | 2020-01-26 | 2023-04-21 | メインライン バイオサイエンシーズ（シャンハイ）シーオー．，エルティーディ． | 同位体標識された選択的ｃｘｃｒ４結合性ペプチドコンジュゲート並びにその作製方法及び使用方法 |
| KR20230092906A (ko) * | 2020-10-21 | 2023-06-26 | 프로빈셜 헬스 서비시즈 오쏘리티 | 신규한 cxcr4 표적화 화합물 |
| CN116615411A (zh) * | 2020-12-25 | 2023-08-18 | 中外制药株式会社 | 包含n-取代氨基酸残基的肽化合物的制造方法 |
| JPWO2022138891A1 (cg-RX-API-DMAC7.html) * | 2020-12-25 | 2022-06-30 | ||
| EP4043041A1 (en) | 2021-02-15 | 2022-08-17 | Technische Universität München | Cxcr4-ligands for diagnostic and therapeutic use and precursors thereof |
| JP2025513489A (ja) * | 2022-04-20 | 2025-04-24 | プロビンシャル・ヘルス・サービシーズ・オーソリティ | Ｃｘｃｒ４標的化合物、およびその作製方法、およびその使用方法 |
| CN115060901A (zh) * | 2022-06-21 | 2022-09-16 | 中国医学科学院基础医学研究所 | 苹果酸酶2在制备矽肺病或肺纤维化相关疾病诊断试剂或治疗药物中的应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4391123B2 (ja) | 2002-10-24 | 2009-12-24 | 株式会社オーファンリンク | 新規ｃｘｃｒ４アンタゴニスト |
| CA2643744A1 (en) * | 2006-02-27 | 2007-08-30 | Technische Universitaet Muenchen | Cancer imaging and treatment |
-
2008
- 2008-05-20 NZ NZ580849A patent/NZ580849A/en not_active IP Right Cessation
- 2008-05-20 MX MX2009012952A patent/MX2009012952A/es active IP Right Grant
- 2008-05-20 EP EP11172401A patent/EP2377579A1/en not_active Withdrawn
- 2008-05-20 PL PL08769524T patent/PL2160221T3/pl unknown
- 2008-05-20 EA EA200971129A patent/EA017716B1/ru not_active IP Right Cessation
- 2008-05-20 MY MYPI20095053A patent/MY149432A/en unknown
- 2008-05-20 KR KR1020097024829A patent/KR101169846B1/ko not_active Expired - Fee Related
- 2008-05-20 CN CN2008800178577A patent/CN101678213B/zh not_active Expired - Fee Related
- 2008-05-20 JO JO2008229A patent/JO2776B1/en active
- 2008-05-20 PT PT08769524T patent/PT2160221E/pt unknown
- 2008-05-20 EP EP08769524A patent/EP2160221B1/en active Active
- 2008-05-20 HR HR20110551T patent/HRP20110551T1/hr unknown
- 2008-05-20 CL CL2008001467A patent/CL2008001467A1/es unknown
- 2008-05-20 JP JP2010510418A patent/JP5358564B2/ja not_active Expired - Fee Related
- 2008-05-20 BR BRPI0812134-6A2A patent/BRPI0812134A2/pt not_active IP Right Cessation
- 2008-05-20 AU AU2008260326A patent/AU2008260326B2/en not_active Ceased
- 2008-05-20 AT AT08769524T patent/ATE516853T1/de active
- 2008-05-20 KR KR1020117026680A patent/KR101319740B1/ko not_active Expired - Fee Related
- 2008-05-20 DK DK08769524.3T patent/DK2160221T3/da active
- 2008-05-20 PE PE2008000868A patent/PE20090299A1/es not_active Application Discontinuation
- 2008-05-20 WO PCT/US2008/064177 patent/WO2008150689A1/en not_active Ceased
- 2008-05-20 TW TW097118554A patent/TWI423987B/zh not_active IP Right Cessation
- 2008-05-20 CA CA2688574A patent/CA2688574C/en not_active Expired - Fee Related
- 2008-05-20 US US12/123,574 patent/US7691813B2/en not_active Ceased
- 2008-05-20 AR ARP080102137A patent/AR066648A1/es unknown
-
2009
- 2009-10-22 IL IL201685A patent/IL201685A/en not_active IP Right Cessation
- 2009-11-10 CR CR11105A patent/CR11105A/es not_active Application Discontinuation
- 2009-11-25 ZA ZA2009/08345A patent/ZA200908345B/en unknown
- 2009-11-26 GT GT200900304A patent/GT200900304A/es unknown
- 2009-11-26 TN TNP2009000496A patent/TN2009000496A1/fr unknown
- 2009-11-27 CO CO09135750A patent/CO6241137A2/es active IP Right Grant
- 2009-11-27 DO DO2009000270A patent/DOP2009000270A/es unknown
- 2009-12-21 MA MA32439A patent/MA31666B1/fr unknown
-
2010
- 2010-01-25 US US12/692,788 patent/US20100130409A1/en not_active Abandoned
- 2010-09-10 US US12/807,694 patent/USRE42274E1/en not_active Expired - Fee Related
-
2011
- 2011-09-07 CY CY20111100861T patent/CY1111815T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20110551T1 (hr) | Antagonisti cikličkog peptida cxcr4 | |
| JP2010529957A5 (cg-RX-API-DMAC7.html) | ||
| AU2018387418B2 (en) | Bicyclic peptide ligands specific for EphA2 | |
| CN102741269B (zh) | Gadd45β靶向剂 | |
| JP2013509861A5 (cg-RX-API-DMAC7.html) | ||
| DE602007011901D1 (de) | Ptiden und zellpenetrierenden peptiden gekoppelt a | |
| Cemazar et al. | Discovery and applications of disulfide-rich cyclic peptides | |
| UA100127C2 (ru) | Пептид cdh3 и лекарственное средство, содержащее его | |
| EP2590992A4 (en) | OPIOID RECEPTOR AGONIST ANALOGUES OF ENDOMORPHINS | |
| CN106232616A (zh) | 两亲性合成抗菌肽、其药物组合物及其用途 | |
| ZA200807027B (en) | Peptides and peptide derivatives, the production thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition | |
| Matheson et al. | Establishing the structure-activity relationship of teixobactin | |
| CN1953989B (zh) | 作为细胞抑制剂的在7位与环肽缀合的喜树碱 | |
| JPWO2020230780A5 (cg-RX-API-DMAC7.html) | ||
| Einsiedel et al. | Peptide backbone modifications on the C-terminal hexapeptide of neurotensin | |
| WO2008070049A8 (en) | Peptide and treatment for hiv-1 infection | |
| Yang et al. | Facile solid phase synthesis of N-cycloguanidinyl-formyl peptides | |
| Aufort et al. | Synthesis and biochemical evaluation of a cyclic RGD oxorhenium complex as new ligand of αVβ3 integrin | |
| EA200801077A1 (ru) | Антагонисты взаимодействия pf4 и rantes | |
| MXPA06012885A (es) | 7-t-butoximinometilcamptotecina conjugada en posicion 20 con antagonistas de integrina. | |
| ES2367941T3 (es) | Antagonistas cíclicos peptídicos de cxcr4. | |
| TH106960A (th) | ไซคลิกเพพไทด์ cxcr4 แอนทาโกนิสต์ | |
| WO2025137159A1 (en) | Human interleukin (il)-17 cytokine binding peptides | |
| Parente | Diketopiperazines as scaffold for the synthesis of new compounds modulating protein-protein interactions and functions | |
| EP3927737A1 (en) | Par4 derived peptides, analogs and uses thereof |